Skip to main content

Published locations for Allo-HSCT in CR1 beneficial for elderly AML patients with unfavorable or intermediate-risk cytogenetics

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Allo-HSCT in CR1 beneficial for elderly AML patients with unfavorable or intermediate-risk cytogenetics

User login

  • Reset your password
  • /content/allo-hsct-cr1-beneficial-elderly-aml-patients-unfavorable-or-intermediate-risk-cytogenetics
  • /hematology-oncology/article/247824/aml/allo-hsct-cr1-beneficial-elderly-aml-patients-unfavorable-or